FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Guidance on Rx Drug Distributor Annual Reporting

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance: Drug Supply Chain Security Act Implementation: Annual Reporting by Prescri...

Panel to Discuss Ferring NDA to Treat Nocturia

[ Price : $8.95]

Federal Register Notice: FDAs Endocrinologic and Metabolic Drugs Advisory Committee will meet 1/12/15 to discuss a Ferring Pharma ...

FDA Accepts NDA from Aprecia Pharma Using Novel Delivery Formulation

[ Price : $8.95]

FDA accepts for filing an Aprecia Pharmaceuticals NDA for the first product using its proprietary ZipDose technology.

QS Problems Found in US Infusion Inspection

[ Price : $8.95]

FDAs Florida District Office warns US Infusion, Inc., about multiple Quality System Regulation violations in its work as a specifi...

AstraZeneca Prevails in Nexium Pay-for-Delay Lawsuit

[ Price : $8.95]

A Boston federal jury finds that a reverse payment or so-called pay-for-delay agreement between AstraZeneca and Ranbaxy Laboratori...

Think Surgical Robotic Surgical System Cleared by FDA

[ Price : $8.95]

Think Surgical gains 510(k) clearance for its new TSolution On Surgical System for total hip arthroplasty.

FDA Draft Guidance on Drug Distributor Annual Reporting

[ Price : $8.95]

FDA releases a draft guidance on Drug Supply Chain Security Act Implementation: Annual Reporting by Prescription Drug Wholesale Di...

FDA Draft Guidance on Pediatric Clin-Pharm Considerations

[ Price : $8.95]

FDA posts a draft guidance on General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products...

FDA Approves New Indication for Amgens Xgeva

[ Price : $8.95]

FDA approves an Amgen supplemental BLA for a new indication for Xgeva (denosumab) treating hypercalcemia of malignancy that is re...

EMA Probes Data Integrity Issues at Indian CRO

[ Price : $8.95]

Several European Union member states suspend the marketing authorizations of medicines that have been authorized on the basis of s...